Guidance and quality standards Awaiting development

Skip to filters Skip to results

Showing 1 to 1 of 1

colorectal cancerRemove colorectal cancer filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter

Guidance and quality standards awaiting development
Title	Type
Favezelimab–pembrolizumab for previously treated PD-L1-positive metastatic colorectal cancer [ID6278]	Technology appraisal guidance

Results per page

10
25
50
All